Dyspepsia
📧 Sign up to get email alerts when something new happens for Dyspepsia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-09FDA Approved: FAMOTIDINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original abbreviated new drug application (ANDA) for famotidine from Aurobindo Pharma Limited, a generic version of famotid…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology [Phase 4]
Phase 4 trial evaluating the effects of high-dose dual therapy and bismuth quadruple therapy for Helicobacter pylori eradication on intestin…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing Vonorazon plus Amoxicillin dual therapy versus a bismuth-containing quadruple regimen for Helicobacter pylori-relate…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Exploratory Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms
A completed exploratory clinical trial assessing the effectiveness and safety of Motilium (domperidone) for OTC treatment of dyspepsia-relat…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
A prospective multicentre real-world study is evaluating the efficacy of Danning Tablets for digestive symptoms, with recruitment ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-05-01Clinical Trial Update: Famotidine and Antacids for Treatment of Dyspepsia [Phase 4]
Phase 4 clinical trial update indicates recruitment for evaluating famotidine with antacids to treat dyspepsia and gastroesophageal reflux d…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Effects of Ondansetron on Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus and Dyspepsia [Phase 2]
Phase 2 clinical trial evaluating the effects of ondansetron on gastrointestinal sensorimotor dysfunction in diabetes mellitus and dyspepsia…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief Study [Phase 3]
Phase 3 clinical trial evaluating Compound Sodium Alginate Double Action Chewable Tablet for symptomatic relief in gastroesophageal reflux d…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting [Phase 1, Phase 2]
Clinical trial update indicating completed Phase 1 and Phase 2 studies evaluating proton pump inhibitors for dyspepsia during Ramadan fastin…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Smartphone App-assisted PPI [NA]
Completed clinical trial evaluating smartphone app-assisted use of proton pump inhibitors for heartburn and dyspepsia.
-
FDA label_change · 2025-01-31FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete chewable tablets (famotidine with calcium carbonate and magnesium hydroxide) sub…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Primary carE PPi dEprescRibing Trial [Phase 4]
Phase 4 deprescribing trial at KU Leuven evaluating stopping or reducing proton pump inhibitors in patients with heartburn, dyspepsia, and g…
-
FDA approval · 2025-01-17FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application to authorize Pepcid Complete chewable tablets (famotidine with calcium carbonate and magnesium h…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
A clinical trial update from Shanghai Jiao Tong University School of Medicine studying the epidemiology of Helicobacter pylori infection and…
-
FDA approval · 2024-11-22FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Naproxen and Esomeprazole Magnesium (ANDA 213699), establishing a generic…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
This clinical trial from Air Force Military Medical University in China investigates the progression from uninvestigated dyspepsia to functi…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults. [NA]
Clinical trial update for De-Stress & Happy Gut Powder assessing effects on stress-related indigestion and dyspepsia in adults; the study is…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Mast Cells in Acid-induced Intestinal Permeability [Phase 4]
A Phase 4 clinical trial investigating the role of mast cells in acid-induced intestinal permeability for dyspepsia has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants [Phase 1]
A first-in-human Phase 1 study comparing a bi-layer calcium carbonate antacid tablet with a standard non-layered calcium carbonate tablet in…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients [NA]
This clinical trial investigates whether Traditional Chinese Medicine affects organ failure outcomes in critically ill patients. The study i…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: The Effect of a Ginger Supplement on Digestive Complaints in Healthy Adults Versus a Placebo [NA]
This clinical trial assesses whether a ginger supplement reduces digestive complaints in healthy adults compared with placebo; the study is …
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: Validation of a Mental Health Scale for Young People With Chronic Stomach Symptoms
This clinical trial update reports on the validation of a mental health scale intended for young people with chronic stomach symptoms, inclu…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA [Phase 3]
Phase 3 clinical trial comparing oral Aroeira against omeprazole for dyspepsia; status: not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Acceptability and Tolerability of Magnetic Assisted Capsule Endoscopy Compared to Gastroscopy [NA]
This completed clinical trial evaluated the acceptability and tolerability of magnetic assisted capsule endoscopy compared with gastroscopy …
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia [Phase 4]
Phase 4 trial update on Galeo® for postprandial distress syndrome subtype in functional dyspepsia completed.